IL6 and Alzheimer disease: Dysregulated IL-6 signaling compromises BBB integrity, allowing peripheral immune cells and inflammatory mediators to infiltrate the brain, further amplifying neuroinflammation and neuronal damage in AD (42, 84, 85).